Adam Winstock

Cited by

	All	Since 2019
Citations	10167	4681
h-index	57	38
i10-index	140	110

980

490

245

735

20012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202427 41 55 56 83 62 100 129 155 181 321 390 436 482 579 681 757 730 768 883 839 968 916 295

Public access

View all

35 articles

3 articles

available

not available

Based on funding mandates

Co-authors

Professor Jason Ferris, PhD MBiostatsDirector of Research and Statistical Services / Program Head Global Substance Use and MentalVerified email at uq.edu.au
Dr Monica J BarrattSenior Research Fellow, Social and Global Studies Centre and Digital Ethnography Research CentreVerified email at rmit.edu.au
Dr Emma L DaviesReader in Psychology, Oxford Brookes UniversityVerified email at brookes.ac.uk
Toby LeaUNSW SydneyVerified email at unsw.edu.au
Tom P FreemanReader, Addiction and Mental Health Group, Department of Psychology, University of BathVerified email at bath.ac.uk
Renee ZahnowThe University of QueenslandVerified email at uq.edu.au
Cheneal PuljevicSenior Research Fellow, The University of QueenslandVerified email at uq.edu.au
Rohan BorschmannProfessorial Fellow, Centre for Mental Heath and Community Wellbeing; University of MelbourneVerified email at unimelb.edu.au
Will LawnKing's College LondonVerified email at kcl.ac.uk
Louisa DegenhardtUniversity of New South WalesVerified email at unsw.edu.au
Richard MattickNational Drug and Alcohol Research Centre, University of New South WalesVerified email at unsw.edu.au
Caitlin HughesMatthew Flinders Fellow, Centre for Crime Policy and Research, Flinders UniversityVerified email at flinders.edu.au
Iain S. McGregorUniversity of SydneyVerified email at sydney.edu.au
Paul GriffithsEMCDDAVerified email at emcdda.europa.eu
Larissa J. MaierIndependent Scientist

Adam Winstock

University College London

Verified email at globaldrugsurvey.com - Homepage

drugs opioid dependence cannabis chem-sex harm reduction drug policy


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
Mephedrone, new kid for the chop? AR Winstock, LR Mitcheson, P Deluca, Z Davey, O Corazza, F Schifano Addiction 106 (1), 154-161, 2011	423	2011
Synthetic cannabis: a comparison of patterns of use and effect profile with natural cannabis in a large global sample AR Winstock, MJ Barratt Drug and alcohol dependence 131 (1-2), 106-111, 2013	355	2013
Drugs and the dance music scene: a survey of current drug use patterns among a sample of dance music enthusiasts in the UK AR Winstock, P Griffiths, D Stewart Drug and alcohol dependence 64 (1), 9-17, 2001	353	2001
Examining the profile of high-potency cannabis and its association with severity of cannabis dependence TP Freeman, AR Winstock Psychological medicine 45 (15), 3181-3189, 2015	312	2015
Mephedrone: use, subjective effects and health risks A Winstock, L Mitcheson, J Ramsey, S Davies, M Puchnarewicz, ... Addiction 106 (11), 1991-1996, 2011	306	2011
Use of S ilk R oad, the online drug marketplace, in the United Kingdom, A ustralia and the United States MJ Barratt, JA Ferris, AR Winstock Addiction 109 (5), 774-783, 2014	281	2014
Ketamine: from medicine to misuse K Wolff, AR Winstock CNS drugs 20, 199-218, 2006	259	2006
Safer scoring? Cryptomarkets, social supply and drug market violence MJ Barratt, JA Ferris, AR Winstock International Journal of Drug Policy 35, 24-31, 2016	230	2016
The prevalence and natural history of urinary symptoms among recreational ketamine users. AR Winstock, L Mitcheson, DA Gillatt, AM Cottrell BJU international 110 (11), 2012	224	2012
Areca nut‐abuse liability, dependence and public health A Winstock Addiction biology 7 (1), 133-138, 2002	177	2002
Up: The rise of nitrous oxide abuse. An international survey of contemporary nitrous oxide use SJ Kaar, J Ferris, J Waldron, M Devaney, J Ramsey, AR Winstock Journal of psychopharmacology 30 (4), 395-401, 2016	175	2016
Ecstasy pill testing: harm minimization gone too far? AR Winstock, K Wolff, J Ramsey Addiction 96 (8), 1139-1148, 2001	172	2001
Definitions related to the use of pharmaceutical opioids: Extramedical use, diversion, non‐adherence and aberrant medication‐related behaviours B Larance, L Degenhardt, N Lintzeris, A Winstock, R Mattick Drug and alcohol review 30 (3), 236-245, 2011	163	2011
No smoke without tobacco: a global overview of cannabis and tobacco routes of administration and their association with intention to quit C Hindocha, TP Freeman, JA Ferris, MT Lynskey, AR Winstock Frontiers in psychiatry 7, 184619, 2016	161	2016
A dependency syndrome related to areca nut use: some medical and psychological aspects among areca nut users in the Gujarat community in the UK AR Winstock, CR Trivedy, K Warnakulasuriya, TJ Peters Addiction Biology 5 (2), 173-179, 2000	146	2000
Mephedrone: still available and twice the price A Winstock, L Mitcheson, J Marsden The Lancet 376 (9752), 1537, 2010	145	2010
Vasopressin and oxytocin secretion in response to the consumption of ecstasy in a clubbing population K Wolff, EM Tsapakis, AR Winstock, D Hartley, D Holt, ML Forsling, ... Journal of Psychopharmacology 20 (3), 400-410, 2006	143	2006
Risk of emergency medical treatment following consumption of cannabis or synthetic cannabinoids in a large global sample A Winstock, M Lynskey, R Borschmann, J Waldron Journal of Psychopharmacology 29 (6), 698-703, 2015	141	2015
The NBOMe hallucinogenic drug series: Patterns of use, characteristics of users and self-reported effects in a large international sample W Lawn, M Barratt, M Williams, A Horne, A Winstock Journal of Psychopharmacology 28 (8), 780-788, 2014	140	2014
Moving on from representativeness: testing the utility of the Global Drug Survey MJ Barratt, JA Ferris, R Zahnow, JJ Palamar, LJ Maier, AR Winstock Substance Abuse: Research and Treatment 11, 1178221817716391, 2017	135	2017

The system can't perform the operation now. Try again later.

Articles 1–20

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Follow

Cited by

Co-authors